Langerhans cell histiocytosis screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}} {{AE}} {{HL}}
{{CMG}} {{AE}} {{HL}}
==Overview==
==Overview==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Langerhans cell histiocytosis.<ref name="US">Recommendations. U.S Preventive Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=Langerhans+cell+histiocytosis+ Accessed on February, 4 2016</ref>
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for Langerhans cell histiocytosis.
==Screening==
==Screening==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Langerhans cell histiocytosis.<ref name="US">Recommendations. U.S Preventive Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=Langerhans+cell+histiocytosis+ Accessed on February, 4 2016</ref>
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for Langerhans cell histiocytosis.<ref name="US">Recommendations. U.S Preventive Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=Langerhans+cell+histiocytosis+ Accessed on February, 4 2016</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|1}}


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
Line 17: Line 17:
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Dermatology]]
[[Category:Surgery]]

Latest revision as of 18:55, 25 March 2019

Langerhans cell histiocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Langerhans cell histiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Langerhans cell histiocytosis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Langerhans cell histiocytosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Langerhans cell histiocytosis screening

on Langerhans cell histiocytosis screening

Langerhans cell histiocytosis screening in the news

Blogs on Langerhans cell histiocytosis screening

Directions to Hospitals Treating Langerhans cell histiocytosis

Risk calculators and risk factors for Langerhans cell histiocytosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Langerhans cell histiocytosis.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Langerhans cell histiocytosis.[1]

References

  1. Recommendations. U.S Preventive Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=Langerhans+cell+histiocytosis+ Accessed on February, 4 2016


Template:WikiDoc Sources